奥翔药业
(603229)
| 流通市值：80.04亿 | | | 总市值：80.04亿 |
| 流通股本：8.30亿 | | | 总股本：8.30亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,149,730,467.72 | 1,222,571,907.8 | 1,129,135,956.12 | 1,146,561,862.52 |
| 交易性金融资产 | 3,874,718.69 | 3,935,980.4 | 6,300,863.46 | 4,792,302.45 |
| 应收票据及应收账款 | 316,746,777.8 | 142,033,885.49 | 206,314,556.58 | 280,160,345.53 |
| 应收账款 | 316,746,777.8 | 142,033,885.49 | 206,314,556.58 | 280,160,345.53 |
| 应收款项融资 | 4,560,422.07 | 4,380,081.71 | 3,488,625 | 4,464,121 |
| 预付款项 | 2,928,330.38 | 1,202,360.98 | 2,196,824.87 | 9,762,927.35 |
| 其他应收款合计 | 1,956,813.43 | 1,788,603.9 | 2,912,597.38 | 1,487,528.73 |
| 存货 | 367,833,357.2 | 398,300,261.45 | 424,356,114.91 | 402,020,054.53 |
| 其他流动资产 | 31,239,580.17 | 41,118,098.04 | 19,000,645.26 | 12,442,520.59 |
| 流动资产合计 | 1,878,870,467.46 | 1,815,331,179.77 | 1,793,706,183.58 | 1,861,691,662.7 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 其他非流动金融资产 | 72,412,803.91 | 72,060,765.18 | 72,060,765.18 | 72,060,765.18 |
| 固定资产 | 743,230,349.41 | 750,512,413.6 | 526,861,022.49 | 534,847,230 |
| 在建工程 | 294,044,692.56 | 285,276,849.26 | 508,388,175.84 | 505,687,350.84 |
| 使用权资产 | 603,063.13 | 847,744.7 | 1,047,565.04 | 1,647,026.06 |
| 无形资产 | 150,555,398.21 | 151,558,909.88 | 152,278,882.35 | 153,290,253.57 |
| 递延所得税资产 | 5,735,813.98 | 3,815,163.01 | 1,261,490.25 | 1,364,656.08 |
| 其他非流动资产 | 10,885,931.4 | 5,347,640.05 | 4,249,805.48 | 3,972,109.14 |
| 非流动资产合计 | 1,277,968,052.6 | 1,269,919,485.68 | 1,266,647,706.63 | 1,273,369,390.87 |
| 资产总计 | 3,156,838,520.06 | 3,085,250,665.45 | 3,060,353,890.21 | 3,135,061,053.57 |
| 流动负债: | | | | |
| 短期借款 | 440,668,599.87 | 410,606,296.16 | 330,970,949.08 | 310,630,493.61 |
| 交易性金融负债 | 3,525,374.18 | 489,448.22 | - | - |
| 应付票据及应付账款 | 225,013,709.87 | 270,095,922.34 | 264,592,277 | 308,824,182.82 |
| 其中：应付票据 | 100,759,504.57 | 83,711,760.8 | 125,168,924.23 | 150,603,488.15 |
| 应付账款 | 124,254,205.3 | 186,384,161.54 | 139,423,352.77 | 158,220,694.67 |
| 合同负债 | 1,099,019.9 | 963,939.05 | 1,187,222.14 | 353,801.89 |
| 应付职工薪酬 | 21,834,317.42 | 42,242,749.91 | 26,888,437.53 | 26,985,595.09 |
| 应交税费 | 16,306,102.78 | 7,848,961.16 | 5,362,420.26 | 6,992,203.43 |
| 其他应付款合计 | 884,239.41 | 1,879,630.63 | 1,465,256.08 | 1,817,702.39 |
| 一年内到期的非流动负债 | 1,559,195.14 | 1,794,630.05 | 1,036,241.73 | 1,256,360.9 |
| 其他流动负债 | 195,104.24 | 98,293.99 | 121,912.04 | 33,577.71 |
| 流动负债合计 | 711,085,662.81 | 736,019,871.51 | 631,624,715.86 | 656,893,917.84 |
| 非流动负债: | | | | |
| 长期借款 | 43,993,927.58 | 44,248,927.58 | 44,225,000 | 18,790,172.5 |
| 租赁负债 | - | - | 399,978.5 | 857,925.58 |
| 递延收益 | 34,572,651.69 | 35,623,652.73 | 36,803,563.82 | 32,809,586.94 |
| 非流动负债合计 | 78,566,579.27 | 79,872,580.31 | 81,428,542.32 | 52,457,685.02 |
| 负债合计 | 789,652,242.08 | 815,892,451.82 | 713,053,258.18 | 709,351,602.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 830,297,145 | 830,297,145 | 830,297,145 | 830,297,145 |
| 资本公积 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 |
| 减:库存股 | 50,010,777.47 | 50,010,777.47 | 50,010,777.47 | 15,537,304.49 |
| 其他综合收益 | -807,659.09 | -1,095,052.34 | -812,529.15 | -823,045.79 |
| 盈余公积 | 146,421,621.66 | 146,468,683.65 | 129,879,465.56 | 129,879,465.56 |
| 未分配利润 | 1,001,060,598.06 | 903,472,864.97 | 997,721,978.27 | 1,041,667,840.61 |
| 归属于母公司股东权益合计 | 2,367,186,277.98 | 2,269,358,213.63 | 2,347,300,632.03 | 2,425,709,450.71 |
| 股东权益合计 | 2,367,186,277.98 | 2,269,358,213.63 | 2,347,300,632.03 | 2,425,709,450.71 |
| 负债和股东权益合计 | 3,156,838,520.06 | 3,085,250,665.45 | 3,060,353,890.21 | 3,135,061,053.57 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-31 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |